Is this you?
Request access for South Broward Research with your @southbrowardresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
South Broward Research
Unclaimed profileIndependent Network · Pembroke Pines, FL · ~1 sites
Intera lens
ICP 5Lift (cardio sample) 0.43Recruit soph 0.57
Quality Scorecard (1–100)
Overall84Recruit74Ops91Sponsor81Ther89
Performance (observed)
Historical trials
404
Completed
262
Terminated/Withdrawn
32
Completion rate
89%
Active now
101
Phase 2
78
Phase 3
255
Realized enrollment
567,942
First study year
1988
Years active
38
Match confidence
high
Enrollment velocity (inf)
14,946
Therapeutic
Areas
Type 2 Diabetes, Hypertension, Hyperlipidemia, COPD, Overactive Bladder, Obesity, Gout, Arthritis
Specialties
Type 2 Diabetes, Hypertension, Hyperlipidemia, COPD, Overactive Bladder, Osteoarthritis, Obesity
Breadth (conditions)
978
Languages
English, Spanish
States
FL
Recruitment (web observed)
Trial Finder
Yes
Patient database
Y (extensive research database)
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Yes - blog posts on obesity/diabetes/disease management
Capability notes
Extensive patient database; recruitment to retain strategy; multi-therapeutic; Phase II-IV focus
Relationships
Sponsors
Children's Oncology Group; National Cancer Institute (NCI); Novo Nordisk A/S; Pfizer; SWOG Cancer Research Network; Alliance for Clinical Trials in Oncology
CROs
ICON Clinical Research; MicroPort CRM; Premier Research; Teva Branded Pharmaceutical Products R&D, Inc.
Owner / parent
Unknown
Expansion
N (single Miramar location noted)
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
mmhartmann@southbrowardresearch.com
Tech & DCT
eSource
Yes
Builds tech
Vendors (eSource/eRegulatory)
Tech stack
eSource, eRegulatory platforms
Recruiting visible
Y
Notes
Single site in Southwest Broward County; 80+ Phase II-IV trials conducted; multi-therapeutic capability; good patient recruitment emphasis; modest scale; no site network expansion; moderate Intera fit—decent therapeutic breadth and recruitment focus but single location limits scale. [Validated: 7 active recruiting cardiometabolic trials on ClinicalTrials.gov.]
Recommendation features (sample indication)
Ind fit 1.00Liftability 0.43Overall84
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.